Business Formation Contracts & Agreements in the Biotechnology Industry
44 Contracts & Agreements
- Articles of Amendment (7 contracts from 5 companies)
- Articles of Incorporation (1 | 1)
- Limited Liability Company Agreements (29 | 22)
- Limited Partnership Agreements (7 | 7)
- AGIOS PHARMACEUTICALS INC (1 contract)
- ALNYLAM PHARMACEUTICALS, INC. (1)
- Aravive, Inc. (1)
- Athenex, Inc. (2)
- BridgeBio Pharma, Inc. (2)
- CANCER GENETICS, INC (1)
- Capstone Therapeutics Corp. (1)
- Cellectar Biosciences, Inc. (1)
- Coherus BioSciences, Inc. (1)
- CTI BIOPHARMA CORP (1)
- Cullinan Oncology, LLC (1)
- Dermira, Inc. (1)
- GENELUX CORP (1)
- GENEREX BIOTECHNOLOGY CORP (1)
- HedgePath Pharmaceuticals, Inc. (1)
- Homology Medicines, Inc. (1)
- iBio, Inc. (2)
- Immune Therapeutics, Inc. (2)
- INTREXON CORP (2)
- Kadmon Holdings, Inc. (1)
- LA JOLLA PHARMACEUTICAL CO (1)
- ORAGENICS INC (2)
- ORGANOVO HOLDINGS, INC. (1)
- Orgenesis Inc. (2)
- PIERIS PHARMACEUTICALS, INC. (1)
- PROGENITY, INC. (2)
- Retrophin, Inc. (1)
- RITTER PHARMACEUTICALS INC (1)
- Spectrum Pharmaceuticals, Inc. (1)
- Vericel Corp (2)
- Virios Therapeutics, LLC (1)
- vTv Therapeutics Inc. (2)
- Zentalis Pharmaceuticals, LLC (2)
- Contingent Value Rights Agreement, dated October 7, 2024, by and between Virios Therapeutics, Inc and Broadridge Corporation Issuer Solutions, LLC a Pennsylvania limited liability... (Virios Therapeutics, LLC, Filed With SEC on November 8, 2024)
- Amended and Restated Limited Liability Company Agreement of GondolaBio, LLC, dated as of August 16, 2024 (BridgeBio Pharma, Inc., Filed With SEC on August 21, 2024)
- Amended and Restated Articles of Incorporation, as amended on April 22, 2024 (PIERIS PHARMACEUTICALS, INC., Filed With SEC on August 14, 2024)
- Amendment No. 1 to Second Amended and Restated Limited Liability Company Agreement of Morgenesis LLC (Orgenesis Inc., Filed With SEC on July 7, 2023)
- Form of Second Amended and Restated Limited Liability Company Agreement of Morgenesis LLC (Orgenesis Inc., Filed With SEC on November 7, 2022)
- Amended and Restated Limited Liability Company Agreement, by and between the registrant, TVAX Biomedical, Inc. and V2ACT Therapeutics, LLC, dated January 3, 2019 (GENELUX CORP, Filed With SEC on June 24, 2022)
- Amended and Restated Limited Liability Company Agreement, dated March 10, 2022, by and among Oxford Biomedica Solutions LLC (f/k/a Roadrunner Solutions LLC), Homology Medicines,... (Homology Medicines, Inc., Filed With SEC on March 23, 2022)
- Sublicense Agreement, dated February 16, 2012, by and among Ligand Pharmaceuticals Incorporated, a Delaware corporation, Pharmacopeia, Inc., a Delaware limited liability company,... (Retrophin, Inc., Filed With SEC on February 24, 2022)
- Third Amended and Restated Limited Liability Company Agreement, dated December 16, 2020, by and among Cullinan Oncology, LLC and its members (Cullinan Oncology, LLC, Filed With SEC on December 18, 2020)
- Nominee Agreement, by and among Avero Laboratory Holdings, LLC, a Delaware limited liability company, Mattison Pathology, LLP d/b/a Avero Diagnostics, a Texas limited liability... (PROGENITY, INC., Filed With SEC on December 1, 2020)
- Amendment to Articles of Incorporation filed with the State of Florida on March 12, 2020, 2020 (Immune Therapeutics, Inc., Filed With SEC on June 29, 2020)
- Amendment to Articles of Incorporation filed with the State of Florida on February 6, 2020, together with the Corporate Resolution of the Board of Directors dated February 2, 2020... (Immune Therapeutics, Inc., Filed With SEC on June 29, 2020)
- Nominee Agreement, by and among Avero Laboratory Holdings, LLC, a Delaware limited liability company, Mattison Pathology, LLP d/b/a Avero Diagnostics, a Texas limited liability... (PROGENITY, INC., Filed With SEC on June 18, 2020)
- Certificate of Conversion Converting Zentalis Pharmaceuticals, LLC (a Delaware limited liability company) into Zentalis Pharmaceuticals, Inc. (a Delaware corporation) (Zentalis Pharmaceuticals, LLC, Filed With SEC on May 15, 2020)
- Plan of Conversion Converting Zentalis Pharmaceuticals, LLC (a Delaware limited liability company) into Zentalis Pharmaceuticals, Inc. (a Delaware corporation) (Zentalis Pharmaceuticals, LLC, Filed With SEC on May 15, 2020)
- Tender and Support Agreement, dated as of January 10, 2020, by and among Eli Lilly and Company, Bald Eagle Acquisition Corporation, New Enterprise Associates 13, L.P. and NEA... (Dermira, Inc., Filed With SEC on January 10, 2020)
- Fourth Amended and Restated Limited Liability Company Agreement, dated November 20, 2018, by and among BridgeBio Pharma LLC and its members (BridgeBio Pharma, Inc., Filed With SEC on May 24, 2019)
- LIMITED LIABILITY COMPANY AGREEMENT OF PETERSON ATHENEX PHARMACEUTICALS, LLC (Athenex, Inc., Filed With SEC on May 12, 2017)
- ADDENDUM OF ADDITIONAL PRODUCT ADDED TO THE LIMITED LIABILITY COMPANY AGREEMENT OF PETERSON ATHENEX PHARMACEUTICALS, LLC DATED OCTOBER 4TH, 2016 November 29, 2016 (Athenex, Inc., Filed With SEC on May 12, 2017)
- AMENDMENT NO. 1 TO Amendedand Restated Limited Liability Company Agreement Of iBioCMO LLC February 23, 2017 (iBio, Inc., Filed With SEC on February 24, 2017)
- ACQUISITIONAGREEMENT AMONG GENEREXBIOTECHNOLGY CORPORATION., a Delaware corporation, HEMADIAGNOSTIC SYSTEMS, LLC, a Florida limited liability company AND STEPHENL BERKMAN Andthe... (GENEREX BIOTECHNOLOGY CORP, Filed With SEC on January 20, 2017)
- PLAN OF CONVERSION Converting KADMON HOLDINGS, LLC (a Delaware limited liability company) into KADMON HOLDINGS, INC. (a Delaware corporation) (Kadmon Holdings, Inc., Filed With SEC on July 7, 2016)
- AMENDED AND RESTATED LIMITED LIABILITYCOMPANY AGREEMENT OF IBIO CMO LLC A Delaware Limited Liability Company Dated as of January 13,2016 (iBio, Inc., Filed With SEC on February 22, 2016)
- AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of VTV THERAPEUTICS LLC Dated as of July 29, 2015 (vTv Therapeutics Inc., Filed With SEC on August 4, 2015)
- AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of VTV THERAPEUTICS LLC Dated as of [__________], 2015 (vTv Therapeutics Inc., Filed With SEC on July 23, 2015)
- STATE OF DELAWARE CERTIFICATE OF CONVERSION FROM A DELAWARE LIMITED LIABILITY COMPANY TO A DELAWARE CORPORATION PURSUANT TO SECTION 265 OF THE DELAWARE GENERAL CORPORATE LAW (Capstone Therapeutics Corp., Filed With SEC on June 26, 2015)
- OFFICELEASE Between DOUGLAS EMMETT 1997, LLC, a Delaware limited liability company as Landlord and RITTER PHARMACEUTICALS, INC., a Delaware corporation as Tenant Date June 25, 2013 (RITTER PHARMACEUTICALS INC, Filed With SEC on March 23, 2015)
- DATED 24 OCTOBER 2014 CHROMA THERAPEUTICS LIMITED -and- CTI BIOPHARMACORP. ASSET PURCHASE AGREEMENT relating to the sale and purchase of certain assets from Chroma Therapeutics... (CTI BIOPHARMA CORP, Filed With SEC on November 6, 2014)
- Office Lease THE TOWERS @SHORES CENTER 201 REDWOOD SHORES REDWOOD CITY, CALIFORNIA Between CA-TOWERS AT SHORESCENTER LIMITED PARTNERSHIP, a Delaware limited partnership as... (Coherus BioSciences, Inc., Filed With SEC on September 25, 2014)
- Lease Agreement For 11500 S. Eastern Avenue, Suites 220, 240 & 270, Henderson, Nevada 89052 Between 11500 SouthEastern Avenue, LLC, a Nevada limited liability company Landlord and... (Spectrum Pharmaceuticals, Inc., Filed With SEC on August 8, 2014)
- AMENDED ANDRESTATED LIMITED LIABILITY COMPANY AGREEMENT OF INTREXON ENERGYPARTNERS, LLC Dated as of March 26, 2014 (INTREXON CORP, Filed With SEC on April 4, 2014)
- Office Lease SHOREBREEZE SHOREBREEZEI REDWOOD CITY, CALIFORNIA Between CA-SHOREBREEZELIMITED PARTNERSHIP, a Delaware limited partnership as Landlord, and VERSARTIS, Inc.,... (Aravive, Inc., Filed With SEC on February 18, 2014)
- LIMITED LIABILITY COMPANY AGREEMENT OF S& I OPHTHALMIC, LLC (INTREXON CORP, Filed With SEC on October 30, 2013)
- AMENDED AND RESTATED ARTICLES OF INCORPORATION OF LA JOLLAPHARMACEUTICAL COMPANY Pursuant to Section 910 of the California General Corporation Law (LA JOLLA PHARMACEUTICAL CO, Filed With SEC on September 25, 2013)
- LIMITED LIABILITY COMPANY AGREEMENT OF ONCOSPIRE GENOMICS, LLC (CANCER GENETICS, INC, Filed With SEC on July 12, 2013)
- THE CLARK BUILDING Cambridge, Massachusetts LANDLORD THIRTY-EIGHTSIDNEY STREET LIMITED PARTNERSHIP TENANT AGIOS PHARMACEUTICALS, INC. THE CLARK BUILDING Table of Contents (AGIOS PHARMACEUTICALS INC, Filed With SEC on June 10, 2013)
- Articles of Merger(PURSUANT TO NRS 92A.200)Page 1 (ORGANOVO HOLDINGS, INC., Filed With SEC on January 4, 2012)
- Exhibit2.2(c) REVOLVINGCREDIT AGREEMENT Between: THEKOSKI FAMILY LIMITED PARTNERSHIP, a TexasLimited Partnership as Lender and ORAGENICS, Inc., a FloridaCorporation as Borrower.... (ORAGENICS INC, Filed With SEC on July 7, 2010)
- RESTATED ARTICLES OF INCORPORATION FOR USE BY DOMESTIC PROFIT CORPORATIONS (as amended in electronic format only as of December 14, 2009) (Vericel Corp, Filed With SEC on December 17, 2009)
- ARTICLESOF AMENDMENT TO ARTICLESOF INCORPORATION OF ORAGENICS,INC. (DocumentNumber P96000091949) (ORAGENICS INC, Filed With SEC on October 30, 2009)